Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Zomas · SciRah

Researcher profile · Semantic Scholar

A. Zomas

Share profile

A. Zomas — researcher profile on SciRah

h-index: 24
Works: 75
Citations: 2,015

Most-cited papers

Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG)
E. Kastritis, K. Zervas, A. Symeonidis, E. Terpos +12 more
2009Leukemia200 citations Open access
Semantic Scholar
Outcome of biphenotypic acute leukemia.
S. Killick, E. Matutes, R. Powles, M. Hamblin +5 more
1999Haematologica177 citations
Semantic Scholar
Subcutaneous CAMPATH‐1H in fludarabine‐resistant/relapsed chronic lymphocytic and B‐prolymphocytic leukaemia
Angela L. Bowen, A. Zomas, E. Emmett, E. Matutes +2 more
1997British Journal of Haematology145 citations Open access
Semantic Scholar
Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma.
M. Dimopoulos, G. Hamilos, A. Zomas, D. Gika +7 more
2004The Hematology Journal140 citations
Semantic Scholar
High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents
E. Terpos, E. Katodritou, M. Roussou, A. Pouli +11 more
2010European Journal of Haematology131 citations
Semantic Scholar
Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b).
A. Zomas, E. Matutes, R. Morilla, K. Owusu-Ankomah +2 more
1996Leukemia90 citations
Semantic Scholar
Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma
E. Kastritis, E. Terpos, M. Roussou, M. Gavriatopoulou +10 more
2016Haematologica87 citations Open access
Semantic Scholar
Quantitative flow cytometry can distinguish between normal and leukaemic B‐cell precursors
N. Farahat, D. Lens, A. Zomas, R. Morilla +2 more
1995British Journal of Haematology87 citations
Semantic Scholar
Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemia.
M. Dimopoulos, C. Zervas, A. Zomas, G. Hamilos +6 more
2002Clinical Lymphoma74 citations
Semantic Scholar
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH).
E. Kastritis, M. Kyrtsonis, E. Hadjiharissi, A. Symeonidis +19 more
2009Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis61 citations
Semantic Scholar
Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone.
M. Dimopoulos, C. Tsatalas, A. Zomas, G. Hamilos +5 more
2003Seminars in Oncology50 citations
Semantic Scholar
Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia.
M. Dimopoulos, G. Hamilos, K. Zervas, A. Symeonidis +12 more
2003Annals of Oncology48 citations Open access
Semantic Scholar
The International Prognostic Scoring System for Waldenström’s macroglobulinemia is applicable in patients treated with rituximab-based regimens
M. Dimopoulos, E. Kastritis, S. Delimpassi, A. Zomas +2 more
2008Haematologica47 citations Open access
Semantic Scholar
Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.
M. Dimopoulos, A. Anagnostopoulos, E. Terpos, Panagiotis Repoussis +9 more
2006Haematologica47 citations
Semantic Scholar
Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent
A. Zomas, N. Anagnostopoulos, M. Dimopoulos
2000Bone Marrow Transplantation47 citations Open access
Semantic Scholar
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies
F. Zagouri, E. Kastritis, A. Zomas, E. Terpos +17 more
2017European Journal of Haematology41 citations
Semantic Scholar
Graft-versus-myeloma after donor leukocyte infusion: maintenance of marrow remission but extramedullary relapse with plasmacytomas
A. Zomas, K. Stefanoudaki, M. Fisfis, T. Papadaki +1 more
1998Bone Marrow Transplantation41 citations
Semantic Scholar
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
E. Terpos, K. Ramasamy, N. Maouche, J. Minařík +15 more
2020Annals of Hematology38 citations
Semantic Scholar
Red cell fragmentation (schistocytosis) after bone marrow transplantation
A. Zomas, R. Saso, R. Powles, H. Mackay +3 more
1998Bone Marrow Transplantation36 citations
Semantic Scholar
No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years
E. Kastritis, M. Kyrtsonis, E. Hatjiharissi, A. Symeonidis +22 more
2010American journal of hematology/oncology34 citations Open access
Semantic Scholar
Prognostication in young and old patients with Waldenström's macroglobulinemia: importance of the International Prognostic Scoring System and of serum lactate dehydrogenase.
E. Kastritis, K. Zervas, Panagiotis Repoussis, E. Michali +8 more
2009Clinical Lymphoma & Myeloma30 citations
Semantic Scholar
Predictive factors for response to rituximab in Waldenstrom's macroglobulinemia.
M. Dimopoulos, A. Anagnostopoulos, C. Zervas, M. Kyrtsonis +4 more
2005Clinical Lymphoma29 citations
Semantic Scholar
Polymicrobial bacterial or fungal infections: incidence, spectrum of infection, risk factors, and clinical outcomes from a large hematopoietic stem cell transplant center
Steven Trifilio, Zheng Zhou, Jessica L. Fong, A. Zomas +4 more
2015Transplant Infectious Disease24 citations
Semantic Scholar
Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
J. Mehta, R. Powles, S. Singhal, C. Horton +4 more
1996Bone Marrow Transplantation24 citations
Semantic Scholar
The Combination of Bortezomib, Melphalan, Dexamethasone and Intermittent Thalidomide (VMDT) Is an Effective Treatment for Relapsed/Refractory Myeloma: Results of a Phase II Clinical Trial.
E. Terpos, A. Anagnostopoulos, E. Kastritis, A. Zomas +4 more
200523 citations
Semantic Scholar
Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation
P. Kaloyannidis, M. Hertzberg, K. Webb, A. Zomas +5 more
2019British Journal of Haematology20 citations Open access
Semantic Scholar
Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemia.
J. Mehta, R. Powles, S. Singhal, C. Horton +8 more
1996Seminars in hematology (Print)19 citations
Semantic Scholar
Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
A. Zomas, J. Mehta, R. Powles, Jennifer Treleaven +6 more
1994Bone Marrow Transplantation17 citations
Semantic Scholar
Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis
W. Plattel, A. Bergamasco, F. Trinchese, F. Gavini +7 more
2021Leukemia and Lymphoma16 citations Open access
Semantic Scholar
Prognostic Value of Serum β2-Microglobulin in Patients with Waldenström's Macroglobulinemia Requiring Treatment
A. Anagnostopoulos, K. Zervas, M. Kyrtsonis, A. Symeonidis +6 more
200615 citations
Semantic Scholar
Treatment of Relapsed/Refractory Multiple Myeloma with Thalidomide-based Regimens: Identification of Prognostic Factors
A. Anagnostopoulos, D. Gika, G. Hamilos, K. Zervas +8 more
2004Leukemia and Lymphoma15 citations
Semantic Scholar
T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure.
J. Mehta, R. Powles, S. Singhal, F. Matthey +7 more
1996Bone Marrow Transplantation15 citations
Semantic Scholar
Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries
C. Assaf, N. Waser, M. Bagot, Mary He +9 more
2021Cancers13 citations Open access
Semantic Scholar
Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosus.
T. Karageorgas, A. Zomas, Pinelopi Kazakou, P. Katsimbri +2 more
2016Rheumatology13 citations Open access
Semantic Scholar
Efficacy and safety of front-line treatments for advanced Hodgkin lymphoma: a systematic literature review
M. Dalal, J. Gupta, K. Price, A. Zomas +2 more
2020Expert Review of Hematology11 citations Open access
Semantic Scholar
Primary Treatment with Pulsed Melphalan, Dexamethasone, Thalidomide (MDT) for Symptomatic Patients with Multiple Myeloma ≥ 75 Years of Age.
M. Dimopoulos, Panagiotis Repoussis, E. Terpos, M. Kyrtsonis +10 more
200411 citations
Semantic Scholar
Primary Treatment of Waldenstrom’s Macroglobulinemia (WM) with Dexamethasone, Rituximab and Cyclophosphamide.
M. Dimopoulos, A. Anagnostopoulos, M. Kyrtsonis, C. Tsatalas +9 more
200411 citations
Semantic Scholar
Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia
A. Tsantes, G. Nikolopoulos, P. Tsirigotis, K. Zoi +6 more
2011Blood Coagulation and Fibrinolysis10 citations
Semantic Scholar
Sequential development of myelodysplasia and acute myeloid leukemia but with no karyotypic evolution after autografting in a patient with Philadelphia positive acute lymphoblastic leukemia.
R. Saso, A. Zomas, M. Hamblin, L. Dunlop +6 more
1997Leukemia and Lymphoma9 citations
Semantic Scholar
Myeloma in the Octogenarians: Disease Characteristics and Clinical Outcomes in the Era of Modern Anti-Myeloma Therapy
M. Dimopoulos, E. Terpos, M. Gavriatopoulou, D. Kalapanida +11 more
20147 citations
Semantic Scholar
Frequency and Prognostic Significance of Hypercalcemia in Patients with Multiple Myeloma: An Analysis of the Database of the Greek Myeloma Study Group
E. Kastritis, E. Katodritou, A. Pouli, E. Hatzimichael +13 more
20117 citations
Semantic Scholar
GVL effect in plasmacytoid DC leukemia/lymphoma
P. Kaloyannidis, A. Zomas, G. Paterakis, Chrysanthi Vadikoliou +3 more
2010Bone Marrow Transplantation7 citations
Semantic Scholar
Effectiveness and Safety of Ixazomib-Based Therapy in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated Outside the Clinical Trial Setting Via an Early Access Program (EAP) in Europe: Second Interim Analysis of the 'Use Via Early Access to Ixazomib' (UVEA-IXA) Study
H. Ludwig, E. Terpos, M. Mateos, M. Boccadoro +8 more
20206 citations Open access
Semantic Scholar
Scintigraphy with technetium-99m methoxyisobutylisonitrile in multiple myeloma patients: correlation with the International Staging System.
J. Koutsikos, V. Grigoraki, T. Athanasoulis, A. Velidaki +6 more
2006Hellenic journal of nuclear medicine6 citations
Semantic Scholar
Dose Dependent Long-term In Vivo Remission of AML1/ETO Positive Acute Myeloid Leukemia with G-CSF
A. Zomas, K. Stefanoudaki-Sofianatou, M. Fisfis, N. Anagnostopoulos
2004Hematology6 citations Open access
Semantic Scholar
First‐line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes
A. Avigdor, F. Trinchese, F. Gavini, N. Bent-Ennakhil +4 more
2022eJHaem5 citations Open access
Semantic Scholar
Evolving Treatment Trends in Relapsed/Refractory Multiple Myeloma (RRMM) in Europe from 2016 to 2018: Analysis of a Multi-National Survey
M. Merz, I. Vande Broek, Manuel Delgado Pérez, Brigitte Kolb +6 more
2019Blood5 citations Open access
Semantic Scholar
The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function.
M. Dimopoulos, E. Kastritis, E. Michalis, C. Tsatalas +11 more
20125 citations Open access
Semantic Scholar
Hypercalcemia Remains an Adverse Prognostic Factor for Newly Diagnosed Patients with Symptomatic Multiple Myeloma in the Era of Novel Anti-Myeloma Therapies, Independently of Age, ISS Stage and Treatment Type: An Analysis of 2129 Patients
A. Zomas, E. Terpos, E. Katodritou, A. Symeonidis +16 more
20143 citations Open access
Semantic Scholar
Rapid disease progression in two cases of myelodysplastic syndrome (MDS) following short therapy with G-CSF.
A. Zomas, M. Fisfis, K. Stefanoudaki-Sofianatou
1997Haematologica3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Dimopoulos×23
Invite
M. Dimopoulos — researcher profile on SciRah
E. Terpos×17
Invite
E. Terpos — researcher profile on SciRah
N. Anagnostopoulos×16
Invite
N. Anagnostopoulos — researcher profile on SciRah
E. Kastritis×14
Invite
E. Kastritis — researcher profile on SciRah

×14

Invite

D. Gika — researcher profile on SciRah

Invite

K. Zervas — researcher profile on SciRah

Invite

A. Pouli — researcher profile on SciRah

Invite

Z. Kartasis — researcher profile on SciRah

A. Symeonidis×8

Invite

A. Symeonidis — researcher profile on SciRah

E. Katodritou×8

Invite

E. Katodritou — researcher profile on SciRah

A. Anagnostopoulos×8

Invite

A. Anagnostopoulos — researcher profile on SciRah

M. Kyrtsonis×8

Invite

M. Kyrtsonis — researcher profile on SciRah